Signaling Pathways
-
A3954 ZM323881Target: VEGFRSummary: VEGFR-2/KDR inhibitor,potent and selective
-
A3956 ZosuquidarTarget: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)Summary: MDR modulator
-
N1831 LuteolinTarget: AP-1|MMP|15-lipoxygenasesSummary: Antioxidant and free radical scavenger
-
A8194 ABT-19914 CitationTarget: Bcl-2Summary: Bcl-2 inhibitor,potent and selective
-
A8200 DAPT (GSI-IX)6 CitationSummary: γ-secretase inhibitor,potent and specific
-
A3003 MDV3100 (Enzalutamide)12 CitationTarget: Androgen ReceptorsSummary: Androgen receptor antagonist
-
A3004 Vemurafenib (PLX4032, RG7204)9 CitationTarget: RafSummary: BRAF kinase inhibitor
-
A3005 CAL-101 (Idelalisib, GS-1101)2 CitationTarget: PI3KSummary: PI3K inhibitor
-
A3006 GDC-0068 (RG7440)Target: AktSummary: Pan-AKT inhibitor,highly selective
-
A3007 ABT-263 (Navitoclax)15 CitationTarget: Bcl-2|Bcl-wSummary: Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w